drugset / Trial / NCT00958269
Study to Evaluate Safety and Efficacy of Dutogliptin in Type 2 Diabetes Mellitus Subjects With Moderate and Severe Renal Impairment
RandomizedParallel-groupDouble-blindTreatment
Summary
The purpose of this study is to assess the safety and tolerability of dutogliptin in Type 2 diabetic subjects with moderate or severe renal impairment.
Timeline
- Start
- 2009-08
- Primary completion
- 2011-09
- Completion
- 2011-11
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Dutogliptin | Small molecule | 100 mg | — |
| Subject | Dutogliptin | Small molecule | 200 mg | — |
| Comparator | Sitagliptin | Small molecule | 25 mg | — |
| Comparator | Sitagliptin | Small molecule | 50 mg | — |